tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (CPHRF)
OTHER OTC:CPHRF
US Market

Cipher Pharmaceuticals (CPHRF) Income Statement

Compare
18 Followers

Cipher Pharmaceuticals Income Statement

Last quarter (Q4 2024), Cipher Pharmaceuticals's total revenue was $11.82M, an increase of 140.28% from the same quarter last year. In Q4, Cipher Pharmaceuticals's net income was $3.34M. See Cipher Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 33.36M$ 21.16M$ 20.68M$ 21.94M$ 21.61M
Gross Profit
$ 24.10M$ 17.09M$ 16.68M$ 18.26M$ 18.55M
Operating Expenses
$ 16.25M$ 5.56M$ 5.63M$ 6.45M$ 6.39M
Depreciation and Amortization
$ 4.02M$ 1.23M$ 989.00K$ 701.00K$ 1.21M
EBITDA
$ 11.87M$ 11.53M$ 12.04M$ 13.66M$ 13.40M
Operating Income
$ 7.85M$ 11.53M$ 12.04M$ 11.82M$ 12.20M
Other Income/Expenses
$ -4.89M$ 1.15M$ -560.00K$ -2.00M$ -5.63M
Pretax Income
$ 2.96M$ 12.68M$ 11.48M$ 11.06M$ 6.54M
Net Income
$ 11.54M$ 20.38M$ 26.64M$ 7.76M$ 4.55M
Per Share Metrics
Basic EPS
$ 0.46$ 0.80$ 0.25$ 0.29$ 0.17
Diluted EPS
$ 0.47$ 0.80$ 0.25$ 0.29$ 0.17
Weighted Average Shares Outstanding
24.72M 25.48M 107.49M 26.60M 27.03M
Weighted Average Shares Outstanding (Diluted)
24.57M 25.42M 107.49M 26.83M 27.37M
Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis